Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  EnteroMedics Inc    ETRM

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 1,19 M
EBIT 2016 -27,6 M
Net income 2016 -
Debt 2016 -
Yield 2016 -
Sales 2017 2,39 M
EBIT 2017 -30,1 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 8,43x
Capi. / Sales2017 4,19x
Capitalization 10,0 M
More Financials
Company
EnteroMedics, Inc. is a clinical development stage medical device company that engages in the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.Its proprietary neuroblocking technology is designed to... 
More about the company
Surperformance© ratings of EnteroMedics Inc
Trading Rating : - Investor Rating :
More Ratings
Latest news on ENTEROMEDICS INC
09/27 ENTEROMEDICS INC : Change in Directors or Principal Officers, Financial Statemen..
09/23 ENTEROMEDICS : ETRM) is Pulling its Weight in the Fight Against Obesity
09/20 ENTEROMEDICS INC : Change in Directors or Principal Officers (form 8-K)
09/12 ENTEROMEDICS INC : Change in Directors or Principal Officers, Financial Statemen..
08/23 NOTEWORTHY STOCKS : Enteromedics Inc. Opko Health Inc
08/17 ENTEROMEDICS INC : Change in Directors or Principal Officers, Other Events, Fina..
08/12 ENTEROMEDICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
08/04 ENTEROMEDICS : reports 2Q loss
08/04 ENTEROMEDICS INC : Results of Operations and Financial Condition, Financial Stat..
08/01 GSK and Google parent forge 540 million pound bioelectronic medicines firm
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/27DJBOSTON SCIENTIFIC : to Buy EndoChoice
09/01DJPHILIPS : Appoints IBM Executive Sophie Bechu as Operations Head
08/17DJAGILENT TECHNOLOGIES : Tech Tapers Annual Outlook Amid Slowing Life Sciences Sal..
08/15DJFisher & Paykel Files Patent Infringement Claim Against ResMed
08/02DJCERNER : Edges Annual Revenue Guidance Lower
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/05 Medtech Approvals Of The Strange Kind
2015 EnteroMedics Will Do 1 For 15 Reverse Split - This Is Not A Good Way To Start..
2015 ENTEROMEDICS TO REVERSE SPLIT SHARES : 15
2015 EnteroMedics' (ETRM) CEO Dan Gladney on Q3 2015 Results - Earnings Call Trans..
2015 EnteroMedics - Investors Need To Have Realistic Expectations
Advertisement
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 1,10 $
Spread / Average Target 667%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Dan W. Gladney President, CEO & Class II Director
Mark B. Knudson Non-Executive Chairman
Peter M. Delange Senior VP-Operations & Business Development
Gregory S. Lea Secretary, Chief Financial & Compliance Officer
Scott A. Shikora Chief Medical Officer & VP-Medical Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ENTEROMEDICS INC53.73%10
THERMO FISHER SCIENTIF..10.02%61 529
BOSTON SCIENTIFIC CORP..26.36%31 705
PHILIPS11.84%28 018
INTUITIVE SURGICAL, IN..31.83%27 715
ILLUMINA, INC.-8.02%25 884
More Results